Update on rupatadine in the management of allergic disorders.
about
Lipid Mediators of Allergic Disease: Pathways, Treatments, and Emerging Therapeutic TargetsA Review on Platelet Activating Factor Inhibitors: Could a New Class of Potent Metal-Based Anti-Inflammatory Drugs Induce Anticancer Properties?Pharmacokinetics, Safety and Cognitive Function Profile of Rupatadine 10, 20 and 40 mg in Healthy Japanese Subjects: A Randomised Placebo-Controlled Trial.Rupatadine in Established Treatment Schemes Improves Chronic Spontaneous Urticaria Symptoms and Patients' Quality of Life: a Prospective, Non-interventional Trial.Current treatment options in patients with mastocytosis: status in 2015 and future perspectives.Latest developments in allergic rhinitis in Allergy for clinicians and researchers.Cardiac Safety of Rupatadine in a Single-Ascending-Dose and Multiple-Ascending-Dose Study in Healthy Japanese Subjects, Using Intensive Electrocardiogram Assessments-Comparison With the Previous White Caucasian Thorough QT Study.Recent pharmacological developments in the treatment of perennial and persistent allergic rhinitis.Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis.Allergic rhinitis: pharmacotherapy in pregnancy and old age.Rupatadine: global safety evaluation in allergic rhinitis and urticaria.Transcriptome analysis of severely active chronic spontaneous urticaria shows an overall immunological skin involvement.Comparative efficacy of bilastine, desloratadine and rupatadine in the suppression of wheal and flare response induced by intradermal histamine in healthy volunteers.Rupatadine oral solution for 2-5-year-old children with allergic rhinitis: a safety, open-label, prospective study
P2860
Q28276574-E883FC21-55DD-4371-A199-606BCFFA8230Q33552144-75EADF36-32B2-4D96-8D23-6446E2053DD7Q36134701-C73F2BCA-8DE5-4CBF-8E37-F741E7226405Q36359983-47D56D80-2BA9-43AA-87A6-B5E2A365C1A6Q38370943-87BC21B2-5ACF-44BE-8903-AF5A682338F3Q38600884-67861C10-D014-403E-9A17-A7FAEE00B753Q38649177-6396ED04-AEFF-467E-9500-B655E417B37EQ38708066-662821F5-5F9F-41D1-B088-80B53807E748Q38739710-19493252-47D4-4644-BC6A-11AA25C0C59BQ38833851-9AAC2B6C-94CB-405C-8DE0-BEE6FC4B83B0Q38921694-026068DF-884B-4787-A5AE-F6383DABD694Q47833266-4F84A8C6-EC10-4ED8-9B0B-3B45FBF045ECQ53563461-C7B3C0F2-387F-4987-9902-50A66C2B7B56Q58765003-636EAC98-C979-4F2F-9E7E-1976BF4602C8
P2860
Update on rupatadine in the management of allergic disorders.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Update on rupatadine in the management of allergic disorders.
@en
type
label
Update on rupatadine in the management of allergic disorders.
@en
prefLabel
Update on rupatadine in the management of allergic disorders.
@en
P2093
P2860
P356
P1433
P1476
Update on rupatadine in the management of allergic disorders.
@en
P2093
A Giménez-Arnau
F E R Simons
G Scadding
J Bousquet
M L Kowalski
P2860
P356
10.1111/ALL.12531
P478
70 Suppl 100
P577
2015-01-01T00:00:00Z